Hologic, Inc. logo
Hologic, Inc. (HOLX)
Compare

Hologic, Inc. (HOLX) Shares Outstanding: 0.23

Is Hologic, Inc.’s shares outstanding high or low?

Hologic, Inc.'s shares outstanding of 0.23 is in line with its 5-year average of 0.25, near the low end of its 5-year range (0.23–0.26).

The shares outstanding for Hologic, Inc. (HOLX) is 0.23. It is below its 12-month average by 1.84% (0.23).

HOLX Shares Outstanding Chart

HOLX Shares Outstanding
0.23-3.62% 1Y
Zoom

HOLX Average Shares Outstanding Chart

HOLX Current vs Average Shares Outstanding Chart

HOLX Shares Outstanding Metrics

SHARES OUTSTANDING

0.23

SHARES OUTSTANDING AVG TTM

0.23

SHARES OUTSTANDING AVG 3Y

0.24

SHARES OUTSTANDING AVG 5Y

0.25

SHARES OUTSTANDING AVG 10Y

0.26

SHARES OUTSTANDING AVG 15Y

0.26

SHARES OUTSTANDING AVG 20Y

0.24

CURRENT VS TTM AVG

-1.84%

CURRENT VS 3Y AVG

-5.46%

CURRENT VS 5Y AVG

-7.96%

CURRENT VS 10Y AVG

-12.81%

CURRENT VS 15Y AVG

-13.31%

CURRENT VS 20Y AVG

-4.22%

Share Structure

Shares Outstanding

227.19M

Float Shares

N/A

Stock Price

$76.01

Market Cap

$17.0B

Annual Shares Outstanding History

YearWeighted Average SharesYoY Change
2025227.19M-3.62%
2024235.72M-4.48%
2023246.77M-1.89%
2022251.53M-2.15%
2021257.05M-2.16%
2020262.73M-2.48%
2019269.41M-2.07%
2018275.11M-1.68%
2017279.81M-0.14%
2016280.21M-0.13%
2015280.57M+1.84%
2014275.50M+2.53%
2013268.70M+2.22%
2012262.86M+0.67%
2011261.10M+0.91%
2010258.74M+0.86%
2009256.55M+4.30%
2008245.97M+130.15%
2007106.87M+14.89%
200693.02M+8.61%
200585.65M+5.70%
200481.03M+3.20%
200378.52M+6.57%
200273.68M+19.03%
200161.90M+1.01%
200061.28M+7.65%
199956.92M+6.73%
199853.33M+3.20%
199751.68M+9.93%
199647.01M-

Relationship: Market Cap = Shares Outstanding × Stock Price

Key concepts:

  • Float shares: Shares available for public trading
  • Dilution: When new shares are issued, existing shareholders own less
  • Buybacks: Reduce share count, increasing EPS and ownership stake
  • Stock splits: Increase share count but don't change market cap

Hologic, Inc. Shares Outstanding Formula & Definition

Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Hologic, Inc. Shares Outstanding FAQ

What is the shares outstanding for Hologic, Inc. (HOLX)?
The shares outstanding for HOLX stock is 0.23.
Is Hologic, Inc.'s shares outstanding high or low?
Hologic, Inc.'s shares outstanding of 0.23 is in line with its 5-year average of 0.25, near the low end of its 5-year range (0.23–0.26).
What is the TTM average shares outstanding for Hologic, Inc. (HOLX)?
The TTM average shares outstanding for HOLX stock is 0.23.
What is the 3Y average shares outstanding for Hologic, Inc. (HOLX)?
The 3Y average shares outstanding for HOLX stock is 0.24.
What is the 5Y average shares outstanding for Hologic, Inc. (HOLX)?
The 5Y average shares outstanding for HOLX stock is 0.25.
What is the 10Y average shares outstanding for Hologic, Inc. (HOLX)?
The 10Y average shares outstanding for HOLX stock is 0.26.
What is the 15Y average shares outstanding for Hologic, Inc. (HOLX)?
The 15Y average shares outstanding for HOLX stock is 0.26.
What is the 20Y average shares outstanding for Hologic, Inc. (HOLX)?
The 20Y average shares outstanding for HOLX stock is 0.24.

Hologic, Inc. Shares Outstanding History

DATESHARES OUTSTANDING
2025-09-270.23
2024-09-300.24
2023-09-300.25
2022-09-300.25
2021-09-300.26
2020-09-300.26
2019-09-300.27
2018-09-300.28
2017-09-300.28
2016-09-300.28
2015-09-300.28
2014-09-300.28
2013-09-300.27
2012-09-300.26
2011-09-300.26
2010-09-300.26
2009-09-300.26
2008-09-300.25
2007-09-300.11
2006-09-300.09
2005-09-300.09
2004-09-300.08
2003-09-300.08
2002-09-300.07
2001-09-300.06
2000-09-300.06
1999-09-300.06
1998-09-300.05
1997-09-300.05
1996-09-300.05

About Hologic, Inc.

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

Marlborough, MA
7,063 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini